Since clinical presentation of postoperative HITT and TTP are almost identical, and TTP is not well defined as a disease entity yet, a patient with unexplained thrombocytopenia with thrombotic ...

The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura (TTP).

Adzynma is a purified recombinant form of the ADAMTS13 protein designed to replace the missing or deficient ADAMTS13 enzyme. The Food and Drug Administration (FDA) has approved Adzynma for ...

Please provide your email address to receive an email when new articles are posted on . Adjuvant low-dose rituximab in combination with plasma exchange and steroids appeared effective for the ...

Pseudo-thrombotic microangiopathy (pseudo-TMA) is relatively easy to treat, but it is also easy to mistake for a much more serious condition, thrombotic thrombocytopenic purpura (TTP). In a new report ...

Please provide your email address to receive an email when new articles are posted on . Researchers analyzed the results of therapeutic approaches to increase ADAMTS13 levels prior to elective surgery ...

In a new study by Yale Cancer Center (YCC) researchers, the drug caplacizumab is shown not to be cost-effective in treating thrombotic thrombocytopenic purpura (TTP) when added to the standard-of-care ...

Thrombocytopenia is an atypically low platelet count. Acquired thrombocytopenia is caused by conditions that develop throughout your life instead of genes inherited from birth. Acquired ...

Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer The following represents disclosure information provided by authors of this manuscript. All relationships are considered ...

Over the past 2 decades, postoperative thrombocytopenia associated with CABG has been brought to the attention of cardiac surgeons and hematologists because this complication is not uncommon and can ...